SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 228 filers reported holding SAGE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,324,000 | -87.8% | 33,794 | -89.9% | 0.00% | -88.6% |
Q2 2022 | $10,842,000 | +1599.4% | 335,666 | +1641.4% | 0.04% | +1650.0% |
Q1 2022 | $638,000 | +44.0% | 19,276 | +92.8% | 0.00% | 0.0% |
Q3 2021 | $443,000 | -97.5% | 10,000 | -96.6% | 0.00% | -98.5% |
Q3 2020 | $17,865,000 | +3166.0% | 292,289 | +1435.3% | 0.13% | +2083.3% |
Q1 2020 | $547,000 | -95.0% | 19,038 | -87.5% | 0.01% | -90.8% |
Q4 2019 | $11,009,000 | -28.4% | 152,505 | -5.0% | 0.06% | -41.4% |
Q4 2018 | $15,374,000 | -6.7% | 160,500 | +38.8% | 0.11% | +50.0% |
Q3 2018 | $16,471,000 | +639.3% | 115,593 | +712.3% | 0.07% | +640.0% |
Q2 2018 | $2,228,000 | -95.7% | 14,231 | -95.5% | 0.01% | -95.3% |
Q1 2018 | $51,242,000 | -54.7% | 318,131 | -53.6% | 0.21% | -39.4% |
Q4 2017 | $113,024,000 | +236.1% | 686,200 | +27.1% | 0.35% | +167.4% |
Q3 2017 | $33,630,000 | -35.1% | 539,802 | -17.0% | 0.13% | -38.3% |
Q2 2017 | $51,805,000 | +45.1% | 650,500 | +29.5% | 0.21% | +28.9% |
Q1 2017 | $35,702,000 | +85.3% | 502,343 | +33.1% | 0.17% | +59.6% |
Q4 2016 | $19,268,000 | +81.9% | 377,360 | +64.1% | 0.10% | +70.5% |
Q3 2016 | $10,592,000 | +214.1% | 230,006 | +105.5% | 0.06% | +177.3% |
Q2 2016 | $3,372,000 | +120.4% | 111,909 | +326.3% | 0.02% | +100.0% |
Q4 2015 | $1,530,000 | – | 26,250 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |